Advertisement

Ads Placeholder
Loading...

IDenta Corp.

IDTAPNK
Healthcare
Medical - Diagnostics & Research
$0.17
$0.00(0.00%)
U.S. Market opens in 57h 54m

IDenta Corp. Fundamental Analysis

IDenta Corp. (IDTA) shows weak financial fundamentals with a PE ratio of -10.63, profit margin of -5.36%, and ROE of -8.86%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position85.34%
PEG Ratio0.21
Current Ratio3.89

Areas of Concern

ROE-8.86%
Operating Margin1.46%
We analyze IDTA's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 11.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
11.8/100

We analyze IDTA's fundamental strength across five key dimensions:

Efficiency Score

Weak

IDTA struggles to generate sufficient returns from assets.

ROA > 10%
-3.62%

Valuation Score

Excellent

IDTA trades at attractive valuation levels.

PE < 25
-10.63
PEG Ratio < 2
0.21

Growth Score

Moderate

IDTA shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IDTA maintains a strong and stable balance sheet.

Debt/Equity < 1
0.76
Current Ratio > 1
3.89

Profitability Score

Weak

IDTA struggles to sustain strong margins.

ROE > 15%
-886.47%
Net Margin ≥ 15%
-5.36%
Positive Free Cash Flow
No

Key Financial Metrics

Is IDTA Expensive or Cheap?

P/E Ratio

IDTA trades at -10.63 times earnings. This suggests potential undervaluation.

-10.63

PEG Ratio

When adjusting for growth, IDTA's PEG of 0.21 indicates potential undervaluation.

0.21

Price to Book

The market values IDenta Corp. at 0.83 times its book value. This may indicate undervaluation.

0.83

EV/EBITDA

Enterprise value stands at 10.32 times EBITDA. This signals the market has high growth expectations.

10.32

How Well Does IDTA Make Money?

Net Profit Margin

For every $100 in sales, IDenta Corp. keeps $-5.36 as profit after all expenses.

-5.36%

Operating Margin

Core operations generate 1.46 in profit for every $100 in revenue, before interest and taxes.

1.46%

ROE

Management delivers $-8.86 in profit for every $100 of shareholder equity.

-8.86%

ROA

IDenta Corp. generates $-3.62 in profit for every $100 in assets, demonstrating efficient asset deployment.

-3.62%

Following the Money - Real Cash Generation

Operating Cash Flow

IDenta Corp. generates limited operating cash flow of $-64.47K, signaling weaker underlying cash strength.

$-64.47K

Free Cash Flow

IDenta Corp. generates weak or negative free cash flow of $-76.75K, restricting financial flexibility.

$-76.75K

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

IDTA converts -10.84% of its market value into free cash.

-10.84%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-10.63

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.21

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.83

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.57

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.76

vs 25 benchmark

Current Ratio

Current assets to current liabilities

3.89

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.09

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

0.01

vs 25 benchmark

How IDTA Stacks Against Its Sector Peers

MetricIDTA ValueSector AveragePerformance
P/E Ratio-10.6328.45 Better (Cheaper)
ROE-8.86%763.00% Weak
Net Margin-5.36%-45265.00% (disorted) Weak
Debt/Equity0.760.34 Weak (High Leverage)
Current Ratio3.892795.60 Strong Liquidity
ROA-3.62%-16588.00% (disorted) Weak

IDTA outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews IDenta Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ